Literature DB >> 7531185

Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype.

S Grisanti1, C Guidry.   

Abstract

PURPOSE: To describe and evaluate retinal pigment epithelial (RPE) cell transdifferentiation in vitro and to determine its importance to the development of proliferative vitreoretinal disorders.
METHODS: Porcine RPE cells from single animals were examined at different passages in culture. The authors examined cellular morphology, contraction of a collagenous matrix, and adhesion to fibronectin and type I collagen-coated substrata. These activities were correlated with loss of epithelial characteristics, redistribution of the actin cytoskeleton, and expression of alpha-smooth muscle actin (alpha-SMA), a marker of myoid differentiation.
RESULTS: During routine culture on tissue culture plastic, porcine RPE cells lose epithelial characteristics and acquire a mesenchymal cell-like phenotype. The ability of cultured porcine RPE cells to adhere to and exert tractional forces on an extracellular matrix increases with continued passage in vitro and transdifferentiation. This correlates with the loss of the differentiated epithelial morphology, decreased expression of the epithelial marker cytokeratin 18, redistribution of the actin cytoskeleton, and de novo expression of alpha-SMA.
CONCLUSION: Results indicate that RPE transdifferentiate in culture and that this transition is accompanied by a shift in biologic activities. Therefore, morphologic and behavioral transdifferentiation of these cells in culture are influencing factors in experimental pathology. The potential relevance of these extensive changes to the biology of proliferative vitreoretinal disorders is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531185

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  78 in total

1.  Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor.

Authors:  A Ando; M Ueda; M Uyama; Y Masu; S Ito
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

2.  Chick retinal pigment epithelium transdifferentiation assay for proneural activities.

Authors:  Shu-Zhen Wang; Run-Tao Yan
Journal:  Methods Mol Biol       Date:  2012

Review 3.  Plasma membrane protein polarity and trafficking in RPE cells: past, present and future.

Authors:  Guillermo L Lehmann; Ignacio Benedicto; Nancy J Philp; Enrique Rodriguez-Boulan
Journal:  Exp Eye Res       Date:  2014-09       Impact factor: 3.467

4.  Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis.

Authors:  Andreas Stahl; Lilija Paschek; Gottfried Martin; Nicolas Feltgen; Lutz L Hansen; Hansjürgen T Agostini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-27       Impact factor: 3.117

5.  Scanning and transmission electron microscopic findings during RPE wound healing in vivo.

Authors:  A Oganesian; E Bueno; Q Yan; C Spee; J Black; N A Rao; P F Lopez
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

6.  [Vitreal-induced RPE cell traction. Investigation of pathological vitreous samples in an in vitro contraction model].

Authors:  J Beutel; M Lüke; K-U Bartz-Schmidt; S Grisanti
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

7.  ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium.

Authors:  Roxanne H Croze; David E Buchholz; Monte J Radeke; William J Thi; Qirui Hu; Peter J Coffey; Dennis O Clegg
Journal:  Stem Cells Transl Med       Date:  2014-07-28       Impact factor: 6.940

8.  Differential induction of gene expression by basic fibroblast growth factor and neuroD in cultured retinal pigment epithelial cells.

Authors:  R T Yan; S Z Wang
Journal:  Vis Neurosci       Date:  2000 Mar-Apr       Impact factor: 3.241

9.  Loss of RPE phenotype affects phagocytic function.

Authors:  Wei Feng; Jing J Zheng; Douglas A Lutz; Barbara J McLaughlin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-18       Impact factor: 3.117

Review 10.  [Pharmacological approach to treatment of proliferative vitreoretinopathy].

Authors:  C S Priglinger; S Priglinger
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.